Status:

COMPLETED

Assessment of Adherence to New Oral anTicoagulants in Atrial Fibrillation patiEnts Within the Outpatient registrY

Lead Sponsor:

National Research Center for Preventive Medicine

Conditions:

Atrial Fibrillation

Eligibility:

All Genders

18+ years

Brief Summary

A prospective non-interventional single-centre study aimed to evaluate actual adherence of AF patients using the validated adherence Scale. Primary Study Objective(s) Primary study objective The aim ...

Detailed Description

AF patients from ongoing PROFILE registry will be invited to visit the scientific center. 2 visits with a 6-month interval are expected for each patient as part of routine clinical practice and phone...

Eligibility Criteria

Inclusion

  • Men and women above 18 years of age who were included in the PROFILE registry by the start of the observational study
  • Presence of written informed consent to participate in the study, fill in the study questionnaires and have personal data analyzed
  • Presence of any form of non-valvular atrial fibrillation with CHA2DS2-VASc score of ≥1 or patients with CHA2DS2-VASc score = 0, who are already taking OAK

Exclusion

  • Patients with high bleeding risk, including patients with:
  • Congenital or acquired bleeding disorders
  • Uncontrolled resistant hypertension
  • Exacerbation of gastric and duodenal ulcer
  • Vascular retinopathy
  • Recent history of intracranial or intracerebral hemorrhage
  • Pathology of the brain and spinal cord vessels
  • Recent history of brain, spinal cord or eye surgery
  • History of bronchiectasis or pulmonary hemorrhage
  • A CHA2DS2-VASc score of 0 (OACs are not indicated)
  • Pregnancy, lactation
  • Planned surgery
  • Known hypersensitivity to ingredients of medications used in the study

Key Trial Info

Start Date :

September 5 2017

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

December 28 2018

Estimated Enrollment :

201 Patients enrolled

Trial Details

Trial ID

NCT03790917

Start Date

September 5 2017

End Date

December 28 2018

Last Update

July 16 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

National Research Center for Preventive Medicine

Moscow, Russia, 101990